Active, not recruiting
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
NCT02452008
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Sibley Memorial Hospital Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- University of Chicago Chicago, Illinois, United States
- Johns Hopkins University Baltimore, Maryland, United States